Tacrine for senile dementia of Alzheimer's or Lewy body type.

Tacrine for senile dementia of Alzheimer's or Lewy body type.

Detalhes bibliográficos
Main Authors:	Wilcock, G, Scott, M
Formato:	Journal article
Idioma:	English
Publicado em:	1994

Registos relacionados

Cognitive decline in patients with Alzheimer's disease, vascular dementia and senile dementia of Lewy body type.
Por: Ballard, C, et al.
Publicado em: (1996)

TACRINE AND LECITHIN IN ALZHEIMERS-DISEASE
Por: Wilcock, G
Publicado em: (1990)

Tetrahydrobiopterin metabolism in senile dementia of Alzheimer type.
Por: Morar, C, et al.
Publicado em: (1983)

The differential involvement of subcortical nuclei in senile dementia of Alzheimer's type.
Por: Wilcock, G, et al.
Publicado em: (1988)

Dementia with Lewy bodies.
Por: Wilcock, G
Publicado em: (2003)

PHARMACOKINETICS OF TACRINE HYDROCHLORIDE IN PATIENTS WITH DEMENTIA
Por: Forsyth, D, et al.
Publicado em: (1989)

Tacrine and lecithin in Alzheimer's disease. Negative conclusions not justified.
Por: Wilcock, G
Publicado em: (1994)

Cholinesterase activities in cerebrospinal fluid of patients with senile dementia of Alzheimer type.
Por: Appleyard, M, et al.
Publicado em: (1987)

Pharmacokinetics of tacrine hydrochloride in Alzheimer's disease.
Por: Forsyth, DR, et al.
Publicado em: (1989)

Assessment of the value of therapeutic monitoring of tacrine in Alzheimer's disease.
Por: Roberts, C, et al.
Publicado em: (1998)

Tacrine for Alzheimer's disease: why is it not available on prescription to UK sufferers?
Por: Wilcock, G
Publicado em: (1994)

Cholinesterase inhibition for Alzheimer disease: a meta-analysis of the tacrine trials. Dementia Trialists' Collaboration.
Por: Qizilbash, N, et al.
Publicado em: (1998)

Long-term use of tacrine
Por: Wilcock, G, et al.
Publicado em: (1994)

Long-term use of tacrine.
Por: Wilcock, G, et al.
Publicado em: (1994)

Frontal cortical synaptophysin in Lewy body diseases: relation to Alzheimer's disease and dementia.
Por: Hansen, L, et al.
Publicado em: (1998)

TETRAHYDROBIOPTERIN METABOLISM IN SENILE DEMENTIA OF ALZHEIMER TYPE
Por: Jones, S, et al.
Publicado em: (1987)

Improving the identification of dementia with Lewy bodies in the context of an Alzheimer’s-type dementia
Por: Alan J. Thomas, et al.
Publicado em: (2018-03-01)

Tacrine for Alzheimer's disease.
Por: Qizilbash, N, et al.
Publicado em: (2000)

Lewy body dementia--diagnosis and treatment.
Por: McKeith, I, et al.
Publicado em: (1995)

Serum concentrations of tacrine hydrochloride predict its adverse effects in Alzheimer's disease.
Por: Ford, J, et al.
Publicado em: (1993)

Alzheimer and vascular brain disease: Senile dementia
Por: Eliasz Engelhardt, et al.

The gesture imitation test in dementia with Lewy bodies and Alzheimer's disease dementia
Por: Xudong Li, et al.
Publicado em: (2022-07-01)

Time Perception in Prodromal Alzheimer's Dementia and in Prodromal Dementia With Lewy Bodies
Por: Ming-Chyi Pai, et al.
Publicado em: (2021-10-01)

Clinical experience with and side-effects of tacrine hydrochloride in Alzheimer's disease: a pilot study.
Por: Forsyth, DR, et al.
Publicado em: (1989)

Herpes simplex virus type 1 DNA is present in specific regions of brain from aged people with and without senile dementia of the Alzheimer type.
Por: Jamieson, G, et al.
Publicado em: (1992)

Persistence of cholinergic neurons in the basal nucleus in a brain with senile dementia of the Alzheimer's type demonstrated by immunohistochemical staining for choline acetyltransferase.
Por: Pearson, R, et al.
Publicado em: (1983)

Galanthamine hydrobromide: Interim results of a group comparative, placebo-controlled study of efficacy and safety in patients with a diagnosis of senile dementia of the Alzheimer type
Por: Wilcock, G, et al.
Publicado em: (1997)

Biomarkers for the diagnosis of Alzheimer’s disease, dementia Lewy body, frontotemporal dementia and vascular dementia
Por: Shifu Xiao, et al.
Publicado em: (2019-02-01)

Dementia with Lewy bodies
Por: O. S. Levin, et al.
Publicado em: (2018-11-01)

Neurofilament-Immunoreactive Neurons in Alzheimer's Disease and Dementia with Lewy Bodies
Por: Claire E. Shepherd, et al.
Publicado em: (2002-03-01)

Cholinesterase inhibitor treatment increases phosphotau accumulation in Alzheimer's disease but reduces A beta in dementia with Lewy bodies
Por: Chalmers, K, et al.
Publicado em: (2008)

Frailty in Older Adults with Mild Dementia: Dementia with Lewy Bodies and Alzheimer’s Disease
Por: Miguel Germán Borda, et al.
Publicado em: (2019-04-01)

Vegetable Freshness Perception in Dementia with Lewy Bodies and Alzheimer’s Disease
Por: Yuka Oishi, et al.
Publicado em: (2020-08-01)

Depression in dementia with Lewy bodies: A comparison with Alzheimer's disease.
Por: Pai-Yi Chiu, et al.
Publicado em: (2017-01-01)

Cortical Lewy Body Dementia
Por: W. R. G. Gibb
Publicado em: (1990-01-01)

Association of Parkinson's disease to Parkinson's plus syndromes, Lewy body dementia, and Alzheimer's dementia
Por: Priyadarshi Prajjwal, et al.
Publicado em: (2024-04-01)

Anosmia in dementia is associated with Lewy bodies rather than Alzheimer's pathology.
Por: McShane, R, et al.
Publicado em: (2001)

Apolipoprotein E epsilon 4 allele frequency in patients with Lewy body dementia, Alzheimer's disease and age-matched controls.
Por: St Clair, D, et al.
Publicado em: (1994)

Dynamic functional connectivity changes in dementia with Lewy bodies and Alzheimer's disease
Por: Julia Schumacher, et al.
Publicado em: (2019-01-01)

Neuroinflammation is associated with Alzheimer’s disease co-pathology in dementia with Lewy bodies
Por: Janna van Wetering, et al.
Publicado em: (2024-05-01)